The evolution of mendelian randomization for investigating drug effects
Published version
Repository URI
Repository DOI
Change log
Authors
Abstract
Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.
Description
Keywords
Perspective, Biology and life sciences, Medicine and health sciences
